Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Novamed, Inc. (OTC BB:NVMD.OB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Insider
Recent Events
Aug 30Price hit new 52-week low ($0.011)
Location
623 Hoover Street
Minneapolis, MN 55413
Phone: (612) 378-1437
Fax: (312) 378-0110
Employees (last reported count): 3
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Websites
 ·Home Page
 ·Investor Relations
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 64%
·Institutional: 0% (0% of float)
(one institution)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Novamed, Inc. is a medical device holding company that develops, manufactures and markets hydrogel- and saline-filled breast implant products. The Company currently derives all of its sales revenue from the sale of prosthesis products outside of North America. Novamed manufactures and markets two different pre-filled single-lumen mammary prostheses (breast implants), the Novagold and the Novasaline. Both products are used for routine cosmetic breast augmentation and for breast reconstruction following either subcutaneous or modified radical mastectomy. The Company's flagship product is the Novagold breast implant, which utilizes a unique water-based filling material that is designed to be biocompatible and therefore safe for human use. This product has been approved for sale in Europe under the CE Mark regulatory process since February 1996. The Company has further developed an inflatable Novasaline breast implant product.
More from Market Guide: Expanded Business Description

Financial Summary
Novamed, Inc., is a medical device holding company that develops, manufactures and markets hydrogel and saline filled breast implant products that are used in augmentations, revisions, or reconstructive procedures. For the three months ended 3/31/01, revenues totalled $0 vs. $371 thousand. Net loss rose 22% to $349 thousand. Revenues reflect the suspension of sales due to the MDA alert notice. Higher loss reflects costs of eliminating the German subsidiary.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY1999 Pay

Ruairidh Campbell, 36
Pres, CEO, Chief Financial Officer, Director
$120K
Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- OTC BB:NVMD.OBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 30-Aug-2001
$0.011
Recent Price$0.012
52-Week High
on 7-Sep-2000
$0.281
Daily Volume (3-month avg)4,955 
Daily Volume (10-day avg)8,000 
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y]
52-Week Change-94.3%
52-Week Change
relative to S&P500
-92.3%
Share-Related Items
Market Capitalization$522.0K
Shares Outstanding43.5M
Float15.7M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)-$0.00 
Earnings (ttm)-$0.08 
Earnings (mrq)-$0.01 
Sales (ttm)$0.03 
Cash (mrq)0 
Valuation Ratios
Price/BookN/A 
Price/EarningsN/A 
Price/Sales (ttm)0.36 
Income Statements
Sales (ttm)$770.0K
EBITDA (ttm)-$1.55M
Income available to common (ttm)-$1.56M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter31-Mar-2001
Management Effectiveness
Return on Assets (ttm)-273.65%
Return on Equity (ttm)-3772.95%
Financial Strength
Current Ratio (mrq)1.14 
Debt/EquityN/A 
Total Cash (mrq)$9,000 
Short Interest
Shares ShortN/A 
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 31-Mar-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.